Dyne Therapeutics, Inc. (DYN) Stock Ticker
DYN right now
Market factors today
Unlock the full DYN picture
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.
DYN stock facts
| Ticker symbol | DYN |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $3.0B |
| CEO | John G. Cox |
| Employees | 289 |
| Headquarters | Waltham, MA, US |
| IPO date | 2020-09-17 |
| Website | www.dyne-tx.com |
What you can see for DYN on Tickr
Live DYN price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the DYN report.
Rankings
FAQ
What is the ticker symbol for Dyne Therapeutics, Inc.?
The ticker symbol for Dyne Therapeutics, Inc. is DYN, listed on the NASDAQ Global Select.
What is DYN?
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular…